ERIS Lifesciences
Buying intent
38 tracked signals | Top 15 topics are below | Sales and HR are carrying most of it.
Attention by team
LinkedIn activity, by teamWhere ERIS Lifesciences's own people are actually spending their attention, by team, by topic. Bands run Low to High against the busiest pairing on this page, and each cell also shows how much of that team's own activity it represents.
Topics being researched
30-day windowEvery tracked topic, ranked by volume, not by our guess at what matters. Confidence is the classifier's own certainty that a signal belongs where we've filed it.
11d ago
18d ago
18d ago
3d ago
13d ago
10d ago
10d ago
11d ago
10d ago
26d ago
28d ago
18d ago
11d ago
10d ago
10d ago
Need intent for a specific topic or industry?
We track the full taxonomy across every account in the graph — including themes not shown on this page.
Who's active at ERIS Lifesciences
verified title on fileTitles, seniority and topic straight from each person's own activity, with a LinkedIn link so you can check any of them yourself.
See everyone, not just the first 10
12 people across every department at ERIS Lifesciences, plus a LinkedIn profile link for each.
Primary products / business lines
LinkedIn company profileEris Lifesciences Ltd. is one of India’s fastest-growing pharmaceutical companies, driven by a people-first approach and a strong focus on high-quality, science-led therapies for chronic and lifestyle-related diseases. We are also the youngest pharma company in India to rise into the Top 20 in under 20 years, making us a leading player in the Indian Pharmaceutical Market. Built on a strong belie
Top accounts researching ERIS Lifesciences
names withheld on the public pageThese are companies whose own people brought up ERIS Lifesciences unprompted, not accounts we guessed might be interested. We can't yet tell an implementation partner from a genuine buyer here, names unlock along with the buyer profile below.
57,400 companies · 377,367 people are researching Career Development
ERIS Lifesciences's own team shows 4 signals on this topic. No one outside ERIS Lifesciences has been seen researching the company by name yet — so this is the market it sits in, not a list of its buyers.
- Return to Work990 cos · 2,688 people
- Field Sales751 cos · 2,157 people
Buyer profile
company size · seniorityCompany size and how senior the people involved are, the two things that decide whether this is a real deal. Competitor overlap isn't computed yet for this account.
Buying committee functions
Employee job titles (LinkedIn)Sales — 5 people; Product — 2 people; Marketing — 1 person
What's been said
public posts mentioning ERIS LifesciencesUp to 9 public excerpts naming ERIS Lifesciences from the past 365 days, across LinkedIn, Reddit, X, YouTube and other public sources.
Moving Mountains through Listening: Scaling 'People First' in Pharma Last week, I shared the three pillars that have defined my five years at Eris Lifesciences—Truth of Science, Execution Excellence, and a People First philosophy. The response from my network was overwhelming, particularly around the idea of putting people first. But how do you scale a "People First" culture when managing a team of 90members across diverse geographies of West India? For me, it comes down to one practical application: Leadership is 80% listening. In a high-stakes environment where we handle a 40Cr portfolio, the pressure for results is constant. However, I’ve found that "Execution Excellence" is only possible when every team member feels heard. Here is how I try to practice this daily: - Listening to the Ground Reality: Our team in the field knows the market better than any spreadsheet. By prioritizing their feedback, we align our "Truth of Science" with the actual needs of healthcare professionals. - Empathy as a Performance Metric: Empathy isn't soft; it's strategic. When a leader listens to a team member's challenges, it builds the trust necessary to drive high-level execution. - Collective Ownership: When people are part of the conversation, they take ownership of the results. Managing growth across West India has taught me that while the numbers are important, the people behind the numbers are the real drivers of success. To my fellow leaders: How do you ensure "Listening" remains a priority during your busiest growth cycles . #Leadership #PharmaSales #PeopleFirst #ExecutionExcellence #ErisLifesciences #GrowthMindset
May 2026